Stay updated with breaking news from Patrick Wingrove. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bristol Myers Squibb on Friday sued the US government in an attempt to halt the Medicare drug price negotiation program that analysts believe will involve one of its top-selling medicines.
By Patrick Wingrove (Reuters) - Bristol Myers Squibb Co on Friday sued the U.S. government in an attempt to halt the Medicare drug price negotiation p...
Bristol Myers Squibb Co on Friday sued the U.S. government in an attempt to halt the Medicare drug price negotiation program that analysts believe will involve one of its top-selling medicines, saying it violates the Fifth and First Amendments to the U.S. Constitution. This is the third lawsuit so far challenging the law - part of President Joe Biden’s signature Inflation Reduction Act (IRA) - which the pharmaceutical industry says will curtail profits and compel them to pull back on developing groundbreaking new treatments. U.S. drugmaker Merck & Co and the U.S. Chamber of Comme...
The Biden administration on Friday announced it would impose inflation penalties on 43 drugs for the third quarter of 2023, having fined 27 earlier this year, in a move it said would lower costs... | June 9, 2023
NEW YORK -Merck & Co sued the U.S. government on Tuesday, seeking to halt the Medicare drug price negotiation program contained in the Inflation Reduction Act , which it argues violates the Fifth... | June 10, 2023